Results of screening in early and advanced thoracic malignancies in the EORTC pan-European SPECTAlung platform

Access to a comprehensive molecular alteration screening is patchy in Europe and quality of the molecular analysis varies. SPECTAlung was created in 2015 as a pan-European screening platform for patients with thoracic malignancies. Here we report the results of almost 4 years of prospective molecula...

Descripción completa

Detalles Bibliográficos
Autores principales: Morfouace, M., Novello, S., Stevovic, A., Dooms, C., Janžič, U., Berghmans, T., Dziadziuszko, R., Gorlia, T., Felip, E., Paz-Ares, L., Mazieres, J., O’Brien, M., Bironzo, P., Vansteenkiste, J., Lacroix, L., Dingemans, A. C., Golfinopoulos, V., Besse, B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9117328/
https://www.ncbi.nlm.nih.gov/pubmed/35585228
http://dx.doi.org/10.1038/s41598-022-12056-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9117328/
https://www.ncbi.nlm.nih.gov/pubmed/35585228
http://dx.doi.org/10.1038/s41598-022-12056-0

Ejemplares similares